Search results
Biotechnology company ProQR has announced that its clinical trials of sepofarsen for Leber congenital amaurosis type 10 and ultevursen for USH2A-mediated retinitis pigmentosa will be wound down with immediate effect.
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing
Amar Latif is an adventurer, entrepreneur, TV presenter and public speaker. He became an Ambassador for Retina UK in 2020.
Steve is a Paralympian who was diagnosed with retinitis pigmentosa (RP) in 2011.
The Retina UK community is sometimes targeted by adverts online or in social media, offering invasive treatments for inherited sight loss.
Thursday 15 May 2025, 7.00pm - 8.00pm - via Zoom - Come and join us for our latest meeting where we will be joined by our guest speakers and new sponsors, EMVI - A Mobile Visual Assistant Designed by and for the Visually Impaired.
UK researchers have discovered that passing a weak electrical current between electrodes on a person’s scalp may lead to a reduction in frequency of the visual hallucinations experienced by some people living with sight loss.
Research determines that taking high dose vitamin A supplements does not slow vision loss in people with retinitis pigmentosa (RP).
